Fluidform, a bioprinting startup, successfully printed heart valves using the FRESH technique and new biocompatible materials. In this short interview, Mike Graffeo, CEO of Fluidshorm shared with us this amazing technology, challenges and opportunities with regulation, scalability, and commercialization of tissue engineering /regenerative medicine products in general. Mike Graffeo, CEO, FluidformA senior executive with a proven track record in commercialization of innovative medical technology, Mike is a results-oriented, decisive leader with a track record of successfully growing new businesses in both startup and growth organizations. Throughout his career, he has gained extensive experience translating highly complex devices and clinical data into successful businesses, both in the US and globally. Mike holds a BS in Engineering Physics and an MEng in Mechanical Engineering from Cornell University, as well as an MBA from Harvard Business School. Mike will also be speaking at the upcoming 3DHEALS2020 San Francisco on June 5-6th, 2020, along with 40+ other world-class speakers. See full video, audio, written interview here. Support the showRelevant links: #3dprinted basketball by Wilson: https://www.wilson.com/en-us/explore/basketball/airless-prototype#3dprinting for #performancesports on-demand recording link: https://3dheals.com/courses/3d-printing-for-performance-sports/Youtube link: https://youtu.be/s4nJQVA66Nw